Dr. Robert Wise, MD

Dr. Wise practices at Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Wise's NPI, 1003843657, was assigned on June 27, 2006. Dr. Wise graduated from Harvard Medical School in 1971. Dr. Wise holds Maryland license D20775.

Dr. Wise's primary practice is Johns Hopkins Bayview Medical Center, at 4940 Eastern Avenue, Baltimore, MD 21224 in Baltimore City. The practice phone is (410) 550-0123.

Dr. Wise's primary practice is Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System. Dr. Wise is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Wise to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wise practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Wise's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Wise is licensed in Maryland.

CMS data shows 4,815 Medicare services from Dr. Wise across 9 procedure codes in 2024, for 1,605 Medicare patients. Medicare paid $53,258 for them.

CMS counts 1,605 Medicare patients who saw Dr. Wise in 2024. The largest group is 65 to 74, with 791 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wise's median patient age at 72, with 64% women.

In 2024, Dr. Wise wrote 338 Medicare Part D claims for 42 patients. 38% of them were for generic drugs. CMS names the drug for 260 of them, across 9 drugs with 11 or more claims each, at $64,399 in total drug cost. In 2023, CMS named 191 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Wise for performance year 2024, reported as part of a group. CMS lists Dr. Wise as offering telehealth.

Dmand AI links 328 papers to Dr. Wise, published from 2007 to 2025. 2017 was the busiest year, with 22. The most frequent topics are Pulmonary Disease, Chronic Obstructive, Forced Expiratory Volume and Asthma. Dr. Wise has published most often in Am J Respir Crit Care Med. Dr. Wise's most frequent co-authors are Meilan King Han, MD, Gerard Criner, MD and Mark T. Dransfield.

Dmand AI links Dr. Wise to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Pulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive and Bronchitis, Chronic. Open Payments lists research payments to Dr. Wise that name 1 trial.

CMS Open Payments shows 507 general payments to Dr. Wise from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 81% of the total. AstraZeneca Pharmaceuticals LP paid the most, $195,502. It also lists 75 research payments totaling $198,229 from 2016 to 2025, naming 1 clinical trial.

Dr. Wise graduated from Harvard Medical School in 1971.